CFG
PACB icon

Citizens Financial Group’s Pacific Biosciences PACB Stock Holding History

Citizens Financial Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,274
Closed -$219K – 456
2021
Q2 		$219K Hold
6,274
– – 0.01% 334
2021
Q1 		$209K Buy
+6,274
New +$220K 0.01% 302
2020
Q3 		– Sell
-6,274
Closed -$22K – 718
2020
Q2 		$22K Buy
+6,274
New +$21.4K ﹤0.01% 609
2020
Q1 		– Sell
-9,831
Closed -$51K – 1195
2019
Q4 		$51K Buy
+9,831
New +$50K ﹤0.01% 431

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citizens Financial Group's PACB Position: Q3 2021 in Review

Citizens Financial Group sold out of Pacific Biosciences (PACB) in Q3 2021, closing a stake of 6,274 shares — an estimated $219K sold.

Citizens Financial Group first reported a position in PACB in Q4 2019 and held it in 4 quarters. The position peaked at $219K in Q2 2021. 246 funds tracked by Wall St. Rank hold PACB as of Q3 2021.

  • Citizens Financial Group reported no remaining Pacific Biosciences position as of Q3 2021 after selling out during the quarter.
  • Citizens Financial Group sold 6,274 Pacific Biosciences shares in Q3 2021, an estimated $219K.
  • Citizens Financial Group first reported a position in Pacific Biosciences in Q4 2019 and held it in 4 quarters.
  • Citizens Financial Group's Pacific Biosciences position peaked at $219K in Q2 2021.
  • 246 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2021.

Based on Citizens Financial Group's 13F filing for Q3 2021, filed 5 Nov 2021.